CD33 POSITIVE ACUTE MYELOGENOUS LEUKEMIA

Clinical trials for CD33 POSITIVE ACUTE MYELOGENOUS LEUKEMIA explained in plain language.

Never miss a new study

Get alerted when new CD33 POSITIVE ACUTE MYELOGENOUS LEUKEMIA trials appear

Sign up with your email to follow new studies for CD33 POSITIVE ACUTE MYELOGENOUS LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Engineered immune cells take on tough leukemia in early trial

Disease control Not yet recruiting

This early-stage study tests a new type of CAR-T cell therapy (FO33 CAR-T) for people with acute myeloid leukemia (AML) that has come back or not responded to standard treatments. The therapy uses a patient's own immune cells, modified to target the CD33 protein found on most AML…

Matched conditions: CD33 POSITIVE ACUTE MYELOGENOUS LEUKEMIA

Phase: PHASE1 • Sponsor: Qi deng • Aim: Disease control

Last updated May 17, 2026 10:39 UTC

CD33 POSITIVE ACUTE MYELOGENOUS LEUKEMIA

Get alerted when new CD33 POSITIVE ACUTE MYELOGENOUS LEUKEMIA trials appear

Engineered immune cells take on tough leukemia in early trial